Cargando…
Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
In this report, we present a 37‐year‐old woman with villous cancer who developed AKI after co‐administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.[Image: see text]
Autores principales: | Nakatani, Kaori, Momo, Kenji, Mimura, Takashi, Yoshiizumi, Eri, Sasaki, Tadanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347319/ https://www.ncbi.nlm.nih.gov/pubmed/35937011 http://dx.doi.org/10.1002/ccr3.6081 |
Ejemplares similares
-
Acute Kidney Injury in Pediatric Treated with Vancomycin and Piperacillin-Tazobactam in Tertiary Care Hospital
por: Al Nuhait, Mohammed, et al.
Publicado: (2018) -
1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019) -
Impact of Obesity on Acute Kidney Injury Incidence Among Patients Treated with Piperacillin–Tazobactam and Vancomycin
por: Rutter, W Cliff, et al.
Publicado: (2017) -
1382. Acute Kidney Injury with Piperacillin–tazobactam and Vancomycin in the Intensive Care Unit
por: Smith, Tameka, et al.
Publicado: (2018) -
212. Acute Kidney Injury with Piperacillin-tazobactam versus Cefepime in Combination with Vancomycin
por: Nguyen, Phuong Khanh, et al.
Publicado: (2020)